J 2024

Comparing the Efficacy of Digital and In-Person Weight Loss Interventions for Patients with Obesity and Glycemic Disorders: Evidence from a Randomized Non-Inferiority Trial

MORAVCOVA, Katarina, Marketa SOVOVA, Jaromir OZANA, Martina KARBANOVÁ, Jan KLASEK et. al.

Basic information

Original name

Comparing the Efficacy of Digital and In-Person Weight Loss Interventions for Patients with Obesity and Glycemic Disorders: Evidence from a Randomized Non-Inferiority Trial

Authors

MORAVCOVA, Katarina (203 Czech Republic), Marketa SOVOVA (203 Czech Republic), Jaromir OZANA (203 Czech Republic), Martina KARBANOVÁ (203 Czech Republic, belonging to the institution), Jan KLASEK (203 Czech Republic), Agnieszka Barbara KOLASINSKA (203 Czech Republic) and Eliska SOVOVA (203 Czech Republic)

Edition

Nutrients, Basel, MDPI, 2024, 2072-6643

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30304 Public and environmental health

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.900 in 2022

Organization unit

Faculty of Medicine

UT WoS

001231311000001

Keywords in English

obesity; digital therapeutics; lifestyle intervention; diabetes mellitus type 2; insulin resistance

Tags

Tags

International impact, Reviewed
Změněno: 10/6/2024 08:33, Mgr. Tereza Miškechová

Abstract

V originále

Digital weight loss interventions present a viable and cost-effective alternative to traditional therapy. However, further evidence is needed to establish the equal effectiveness of both approaches. This randomized controlled non-inferiority trial aimed to compare the effects of an intensive in-person weight loss intervention program with Vitadio digital therapy. One hundred patients with obesity and diagnosed with type 2 diabetes, prediabetes, or insulin resistance were enrolled and randomly assigned to one of the two treatment groups. Over a 6-month period, the control group received five in-person consultations with a physician who specialized in obesity treatment, a dietitian and/or a nutrition nurse, while the intervention group followed the digital program based on a multimodal therapeutic approach. The extent of weight loss was assessed and compared between the groups. Additionally, changes in body composition and metabolic parameters for the digital intervention group were analyzed. The study results demonstrated comparable effectiveness of both treatments for weight reduction. The positive effects of Vitadio were further evidenced by favorable changes in body composition and lipid metabolism and improved glycemic control in the intervention group. These findings suggest that Vitadio is an effective tool for assisting patients with managing obesity and preventing diabetes progression.